UGCG and infection: When we treated target cells with PPMP, a broadly utilized inhibitor of UGCG [31–33], we observed a decrease in infection by PR8 influenza virus encoding NS1-GFP, as monitored by flow cytometry for GFP expression (Fig 2A).